Article
Expression of E-cadherin and beta-catenin in primary and peritoneal metastatic ovarian carcinoma.
Oncology reports - 1 Jan 2000
Fujioka T, Takebayashi Y, Kihana T, Kusanagi Y, Hamada K, Ochi H, Uchida T, Fukumoto M, Ito M
Abstract excerpt
Protein expression levels of E-cadherin and beta-catenin were examined in 39 primary and 10 metastatic ovarian carcinoma to elucidate the role of these molecules in the extension of ovarian carcinoma by immunohistochemistry. Twenty-two of 39 (56%) ovarian carcinomas were preserved type and 17 of 39 (44%) were reduced type of E-cadherin. In contrast, 36 of 39 (92%) ovarian carcinomas were preserved type and 3 of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
